PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib

NCT00117299 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: PTK787/ZK222584

Sponsor

University of Helsinki

Collaborators

[object Object]